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ABSTRACT 1 
An experimental system of Mycobacterium tuberculosis growth in a carbon-2 
limited chemostat, has been established using Mycobacterium bovis BCG as a 3 
model organism. In this model carbon-limited chemostats with low 4 
concentrations of glycerol were used to simulate possible growth rates during 5 
different stages of tuberculosis. A doubling time of 23 hours (D=0.03h-1) was 6 
adopted to represent cells during the acute phase of infection whereas a slower 7 
dilution rate, equivalent to a doubling time of 69 hours (D=0.01h-1) was used to 8 
model mycobacterial persistence. This chemostat model allowed the specific 9 
response of the mycobacterial cell to carbon limitation at different growth rates 10 
to be elucidated. Cell macromolecular (RNA, DNA, carbohydrate and lipid) and 11 
elemental (C, H, N) compositions of biomass were determined in steady state 12 
cultures, revealing that carbohydrates and lipids comprised more than half of 13 
the dry mass of the BCG cell, with only a quarter of the dry weight consisting of 14 
protein and RNA. Consistent with studies in other bacteria, the specific growth 15 
rate impacts on the macromolecular content of BCG and the proportion of lipid, 16 
RNA and protein increase significantly with the growth rate. The correlation of 17 
RNA content with growth rate indicates that ribosome production in carbon 18 
limited M. bovis BCG cells is subject to growth rate dependent control. The 19 
results also clearly show that the proportion of lipid in the mycobacterial cell is 20 
very sensitive to changes in the growth rate, probably reflecting changes in the 21 
amounts of storage lipids. Finally this study demonstrates the utility of the 22 
chemostat model of mycobacterial growth for functional genomics, physiology 23 
and systems biology studies. 24 
 3
INTRODUCTION 1 
With three million people dying from tuberculosis annually Mycobacterium 2 
tuberculosis remains a formidable pathogen. Tuberculosis ranks in the top ten causes 3 
of global mortality and morbidity and is the number one leading cause of infectious 4 
disease (66). Fundamental to this organism’s success is its ability to adapt and survive 5 
harsh environmental conditions in order to establish and maintain long-term infections 6 
within its human host. Modification of the mycobacterial cell in response to changes 7 
in the environment is crucial to this adaptive process, however detailed information 8 
about how M. tuberculosis changes its macromolecular composition in response to its 9 
environment and growth rate is lacking.  10 
The genome sequence of M. tuberculosis has been available since 1998 (9). Although 11 
information obtained from the genome sequence provides a new and valuable insight 12 
into the biology of the tubercle bacillus, the genome itself provides few clues as to 13 
how the pathogen responds to its environment by changing its cellular composition. 14 
One of the principal tasks of post-genomic biology of M. tuberculosis is to understand 15 
how the genome orchestrates the structure and dynamics of the cell in response to 16 
changes in the environment. This task requires an integration of information at the 17 
transcriptome (transcriptomics), proteome (proteomics) and metabolome 18 
(metabolomics). There is a need to understand biological processes by integrating all 19 
three levels of cellular information (systems biology), and therefore the system under 20 
study must be defined. An inventory of the macromolecular content of the 21 
mycobacterial cell in specific conditions will help define the system under study and 22 
the reaction of this pathogen to the environment more precisely. This represents a first 23 
step towards a systems biology approach to understanding the TB bacillus  24 
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Quantitative descriptions of the chemical composition of the mycobacterial cell are 1 
limited to a few studies performed many years ago (61, 63-65, 67). These data in 2 
combination with standard mathematical models has allowed mycobacterial 3 
researchers to make useful predictions concerning the chemical composition of an 4 
“average” mycobacterial cell (10-12). However, this recipe does not correspond to a 5 
defined physiological state as the experiments were performed using batch culture 6 
systems. A major limitation of batch culture is that the cells are grown in an 7 
environment that is constantly changing with time as a result of bacterial metabolism. 8 
The excretion of by-products and depletion of nutrients from the medium results in an 9 
undefined environment, which has an unpredictable impact on the physiology and 10 
growth rate of the organism. In addition batch cultivations yield no information about 11 
how the macromolecular content varies with growth rate and specific environmental 12 
conditions and are therefore not amenable to systems biology approaches to modeling 13 
cellular physiology such as metabolic flux analysis (MFA)(48). MFA is a key 14 
technique in metabolic engineering, allowing metabolic phenotypes to be defined in 15 
terms of the carbon flux through a metabolic network using mathematical modeling 16 
and computer simulation. As it is becoming apparent that intricate and controlled 17 
regulation of metabolic processes in response to the host environment is a critical 18 
component of the pathogenic strategy of M. tuberculosis(37) information on the flux 19 
through the major pathways using MFA will be an important strategy for 20 
understanding the changes in metabolism related to the virulence of this organism.  21 
Chemostat cultivation has made it possible to study the physiological impact on 22 
bacteria of specific nutritional conditions at different growth rates. This makes the 23 
chemostat an invaluable tool for investigating the macromolecular composition of the 24 
bacterial cell. The application of continuous culture technology to TB research has 25 
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enormous potential. The chemostat can be used to investigate the effects of growth 1 
rate and nutritional status of mycobacteria on gene expression, metabolism and 2 
physiology. In addition, the chemostat provides a virtually unlimited source of 3 
mycobacterial cells in a defined state, which are ideal for functional genomics, 4 
physiology and systems biology studies. 5 
The slow growth rate of pathogenic mycobacteria, problems associated with clumping 6 
of bacilli and safety considerations have all provided obstacles for researchers 7 
attempting chemostat cultures. As a result only very few projects have utilised the 8 
chemostat for growing this group of organisms (3, 27, 30, 35, 36). A continuous 9 
culture system has been described for M. tuberculosis and has recently been 10 
successfully employed to investigate the effects of 1% oxygen on the transcriptome of 11 
M. tuberculosis (3, 27). This study allowed the effect of oxygen limitation on the 12 
transcriptome of M. tuberculosis to be investigated at a constant growth rate and 13 
independently of any other environmental parameters (3). Mycobacterium bovis 14 
Bacillus Calmette-Guerin (BCG) has also been cultivated successfully in a bioreactor 15 
(16, 30, 42). These studies investigated mycobacterial growth at one specific growth 16 
rate. However, chemostats also provide reasearchers with the unique opportunity to 17 
investigate the effects of different growth rates on bacteria. A recent study 18 
investigating the transcriptional response of E. coli demonstrated that the impact of 19 
slow growth rates on bacteria may be far greater than the effects of nutrient limitation 20 
(24). Furthermore growth rate is a critical issue in the physiology and pathogenesis of 21 
M. tuberculosis. Firstly the organism grows much slower than most other microbes 22 
that have been studied, with a doubling time that does not exceed one division every 23 
16 hours. Secondly infection with M. tuberculosis is characterized by two distinct 24 
phases, an acute phase of the disease in which the organism is assumed to be growing 25 
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at or near its maximum rate and a persistent asymptomatic infection in which the 1 
bacteria are either growing extremely slowly or existing in a non-growing state. 2 
Dissecting the response of mycobacterial populations at different growth rates in a 3 
chemostat may therefore reveal important information about the physiological state of 4 
mycobacteria when growing in the host and offers an attractive approach to modeling 5 
persistence.  6 
To overcome the safety considerations when working with M. tuberculosis the 7 
vaccine strain M. bovis BCG has been used as a model organism in this study. The 8 
BCG vaccine originates from M. bovis attenuated by repeated passaging in vitro and 9 
is therefore very closely related to M. tuberculosis. The genome of M. bovis BCG and 10 
M. tuberculosis exhibit a high degree of homology sharing 99.9% of DNA (34). The 11 
principal genetic difference between the two organisms is that BCG contains a 12 
number of well-defined deletions (4). M. bovis BCG mimics M. tuberculosis in its 13 
ability to persist in the body and is also able to cause reactivation disease in the 14 
immunocompromised host (1, 33, 41, 43, 45, 56). Indeed, survival and persistence of 15 
the live BCG vaccine is necessary to elicit protective immunity. Researchers have 16 
demonstrated similarities between the physiological, molecular and metabolic 17 
responses of M. bovis BCG and that of the tubercle bacillus (19, 25, 29, 29, 40). 18 
Studying M. bovis BCG may help formulate hypotheses about pathogenic 19 
mechanisms of TB, which can then be tested in M. tuberculosis.  20 
It is postulated that slow growth rates and carbon limitation may be characteristics of 21 
M. tuberculosis in vivo. In an effort to mimic possible in vivo conditions a chemostat 22 
model system of mycobacterial growth has been developed using M. bovis BCG as a 23 
surrogate for M. tuberculosis. The bacteria in this model are in a defined glycerol-24 
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limited environment and replicating at known sub-optimal growth rates. Therefore 1 
this system will be useful for modeling mycobacterial disease. Seminal experiments 2 
with Escherichia coli have demonstrated that the size and composition of the bacterial 3 
cell are sensitive functions of growth rate and that the composition of the environment 4 
is paramount in determining both the viability and the rate of bacterial growth (6, 15). 5 
To determine whether remodelling of the mycobacterial cell also occurs in response to 6 
changes in the growth rate the macromolacular composition of M. bovis BCG was 7 
investigated in the chemostat model of mycobacterial growth. This is the first study to 8 
investigate the influence of specific growth rate in chemostat culture on the 9 
physiological behaviour of mycobacteria and provided valuable information to 10 
elucidate changes in metabolic flux distributions and cell adaptation. 11 
MATERIALS AND METHODS 12 
Bacterial strains. M. bovis BCG Pasteur, which was originally purchased from the 13 
American Type Culture Collection  (ATCC) 35748 was used in this study. Small 14 
aliquots of seed stocks were maintained in 10% (vol/vol) glycerol at -800C. 15 
Media. Middlebrook 7H11 agar and Middlebrook 7H9 broth containing 5% (vol/vol) 16 
OADC enrichment media supplement (Becton Dickenson) and 0.5% (vol/vol) 17 
glycerol were used to grow cultures from frozen stocks and for counting the number 18 
of culturable bacteria in chemostat samples.  Brain Heart Infusion agar (BHI) was 19 
used to assess the culture purity (Becton Dickenson). Roisin’s minimal medium was 20 
used for the cultivation of M. bovis BCG in continuous culture (R. M. Owens, 21 
personal communication). Roisin’s was prepared as follows: KH2PO4, 1g l-1; 22 
Na2HPO4, 2.5g l-1; NH4Cl, 5.9g l-1; K2SO4, 2.0 g l-1; ZnCl2, 0.08 mg l-1; FeCl3, 0.4 mg 23 
l-1; CuCl2, 0.02 mg l-1; MnCl2, 0.02 mg l-1; Na2B4O7, 0.02 mg l 1; NH4MoO4, 0.02 mg 24 
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l-1; Tween 80, 0.2% (v/v); Biotin, 0.5mg l-1; glycerol, 5ml l-1; antifoam (Breox FMT 1 
30), 0.05 % (vol/vol). The pH was adjusted to pH 6.6 and sterilised by filtration 2 
through a 0.2µm Sartorius filter.  3 
Continuous culture of M. bovis BCG.  M. bovis BCG was grown in glycerol limited 4 
steady state cultures in 2 litre bioreactors fitted with a sealed titanium top plate. The 5 
culture system was operated as a chemostat by controlling nutrient addition from the 6 
medium reservoir using a Gilson Minipuls3 peristaltic pump, while a constant volume 7 
of 1 litre was maintained via an overflow tube attached to another pump (Watson 8 
Marlow). Medium delivery was monitored daily. The culture was stirred using an 9 
impeller set between 750-1000 rpm. Culture conditions were continuously controlled 10 
by either a Biolab Fermentation system (Braun) or the Adaptive Biosystem Voyager 11 
system (Adaptive Biosystems). The temperature was measured with a Biolab 12 
temperature probe and kept constantly at 370C with a heating rod. Culture pH was 13 
monitored using an Ingold pH electrode (Broadley-James) and maintained at 6.6 by 14 
the automatic addition of either 1M NaOH or 1M HCl. The dissolved oxygen 15 
concentration was monitored with a polarographic oxygen electrode (Broadley-James) 16 
and was controlled at 70-100 % by feedback control of the stirring rate. Air was 17 
pumped through a filter into the headplate at a constant rate of 0.1 l min -1. Effluent 18 
gas was passed through a cooling condenser to minimise evaporative loss and 19 
analysed continuously using an infrared (CO2) and electrochemical galvanic (O2) 20 
analysers (Adaptive Biosystems Dual Gas Tandem sensor). 21 
Inoculum cultures were grown in 100 ml of modified Roisin’s medium in glass flasks 22 
containing a Teflon-coated magnetic bar on a magnetic stirrer until late exponential 23 
phase (OD600 =1.0). This BCG preculture was transferred into the vessel through the 24 
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inoculum port. After inoculation the culture was allowed to grow batchwise until the 1 
OD600 reached approximately 1.0. Continuous culture was then started at a known 2 
dilution rate of 0.03 h-1 (equivalent to a doubling time, td of 24 hours) or 0.01 h-1 (td = 3 
69 hours). Four volume changes were allowed to ensure the cultures had reached 4 
steady state, confirmed by constancy in oxygen consumption, carbon dioxide and 5 
biomass production. Once the steady state was reached cells were harvested for 6 
analysis. In order to minimise the chances of a spontaneous mutant supplanting the 7 
original strain of BCG each chemostat culture was performed independently. 8 
Culture analyses. Culture samples were withdrawn from the chemostat by a tube 9 
submerged in the culture broth, and collected into a sterile bottle kept in an ice bath. 10 
The optical density of culture samples was recorded at 600 nm (OD600) using a 11 
Pharmacia Biotech Ultraspec 200 UV visible spectrophotometer against a water 12 
reference. Biomass was determined according to the method described by Lynch and 13 
Bushell (32). Acid fastness was determined by a modified Ziehl-Neelson stain (BDH) 14 
according to the manufacturer’s protocol. Viable counts were measured by plating 15 
100 µl aliquot of decimal dilutions in sterile Ringer’s solution plus 0.01% (v/v) 16 
Tween 80 onto Middlebrook 7H11 agar. Mycobacterial colonies were enumerated 17 
after 3-4 weeks incubation at 370C. The purity of the chemostat culture during the 18 
experiments was monitored by daily Gram staining and culturing of samples on Brain 19 
Heart Infusion agar.  20 
Chemical assays. Samples were collected on ice and harvested by centrifugation at 21 
13,000 g for 15 minutes at 40C. The supernatant was filtered through a 0.2µm 22 
syringe filter and stored at –200C until analysed. The glycerol in the supernatant and 23 
fresh medium was assayed using a commercial assay kit that employs a glycerokinase 24 
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coupled enzyme assay system (Boehringer Manheim). Phosphate and ammonia were 1 
quantified by reflectometry (Rqflex, Merck). The cell pellet was washed twice in PBS 2 
and then stored at –800C. Prior to analysis samples were dried for at least 12 hours in 3 
an Edwards Modulyo freeze dryer and stored in an evacuated dessicator.  4 
Macromolecular composition. The macromolecular composition of cellular biomass 5 
was determined from freeze-dried cell pellets. Total carbohydrates were assayed by 6 
the phenol reaction using glucose as a standard (17, 65). Total protein was extracted 7 
using two different methods: (1) Cells were boiled in 0.5M sodium hydroxide for 10 8 
minutes; (2) Cells were resuspended in a protein solubilisation buffer containing 9M 9 
urea, 2% (w/v) CHAPS (3-3-chloromidopropyldimethylammoniol-proane 10 
sulphonate), 2% (w/v) SB 3-10 (3-[Decyldmethylammonio] propane sulfonate) and 11 
transferred to 2ml ribolysor tubes containing 0.5g of glass beads (150-212 microns, 12 
Sigma-Aldrich). The mixture was vortexed for 30 seconds, cooled on ice for 10 13 
minutes, and lysed using a Ribolyser (Hybaid) (speed setting of 6.5 for 30s  4) with 14 
careful cooling in between cycles. The cell free supernatant was collected by 15 
centrifugation at 4,000 g for 10 minutes at 140C. Total cellular protein was measured 16 
by the Lowry method (31) and by the PlusOne 2-D Quant Kit (Ammersham). Bovine 17 
serum albumin was used as a standard and was included with each set of samples.  18 
The extraction procedure for DNA was performed as described by Winder et al. (60) 19 
and measured by the phenylalanine reaction using calf thymus DNA (Sigma) as a 20 
control (13, 62). For the RNA extraction 20ml of culture sample was rapidly 21 
withdrawn from the chemostat by a tube submerged in the culture broth and directly 22 
injected into a sterile bottle containing 80ml of GTC solution (5M guanidinium 23 
thiocyanate, 0.5% (vol/vol) sodium N-lauryl sarcosine, 25mM tri-sodium citrate and 24 
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0.1M DTT). RNA was then prepared essentially as described by Stewart et al.  (54). 1 
To remove contaminating DNA, samples were digested with 2 units DNase I for 30 2 
minutes at 370C (Ambion). The enzyme and divalent cations were then removed using 3 
DNase Inactivation Reagent (Ambion). Total RNA concentrations were measured 4 
using the RiboGreen RNA quantification kit (Molecular Probes) according to the 5 
manufacturers instructions and expressed relative to dry weight.  6 
 Lipid extractions were performed as described by Winder and O’ Hara (60) replacing 7 
the final benzene treatment with an ethanol-ether (3:1) extraction at 600C for 10 8 
minutes. Carbon (C), hydrogen (H) and nitrogen (N) composition of dried biomass 9 
and lipid extractions were determined by a CHN-elemental analyser CE-440 (Exeter 10 
Analytical). All chemical determinations were performed a minimum of three times 11 
from two independent chemostat cultivations. A standard error of the mean of less 12 
than 10% was achieved for all assays with a mean standard error of 5.29%. 13 
RESULTS 14 
Chemostat culture. The first goal of this study was to develop and optimise 15 
conditions for growing BCG continuously in a fermenter. James and colleagues have 16 
successfully cultivated M. tuberculosis using a complex nutrient rich medium 17 
containing several carbon sources and an almost full complement of amino acids, but 18 
this medium is unsuitable for physiological studies due to difficulties in identifying 19 
the growth limiting substrate (3, 27). For physiological studies in chemostat cultures it 20 
is desirable to use defined media, containing ingredients that can be easily monitored 21 
throughout the experiment. For this reason Roisin’s medium was investigated in this 22 
study as the base medium for the growth of M. bovis BCG. Roisin’s has significant 23 
advantages over other media described for culturing mycobacteria in a chemostat as it 24 
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is inexpensive, minimal, chemically defined and contains only one source of carbon 1 
plus Tween 80 as a dispersal agent. In addition the carbon, nitrogen and phosphate 2 
sources are easily measured using simple assays and therefore continuous cultivation 3 
of mycobacteria in this medium is amenable to other physiologically relevant studies, 4 
such as metabolic flux analysis.   5 
The medium composition was modified slightly for the cultivation of M. bovis BCG 6 
by the addition of the vitamin biotin, which is known to enhance the growth of 7 
M. bovis BCG (2). Initial experiments investigated the ability of Roisin’s medium to 8 
support batch growth of M. bovis BCG in a bioreactor. Short lag phases and fast rates 9 
of growth were observed (data not presented). Results indicated that maximal specific 10 
growth rate for BCG in Roisin’s medium, calculated by measuring the growth rate 11 
during the log phase of growth, was approximately 0.033h-1, corresponding to a 12 
doubling time of 21 hours. Analysis of the composition of the growth medium 13 
indicated that phosphate and ammonia remained in excess throughout the growth 14 
cycle, whereas glycerol was only present in trace amounts, confirming that Roisin’s 15 
was a glycerol-limited culture medium. Whilst the environmental milieu encountered 16 
by persisting M. tuberculosis remains relatively undefined and hotly debated, 17 
evidence suggests that the phagosomal environment is carbohydrate poor and 18 
therefore Roisin’s provided an appropriate medium for modeling mycobacterial 19 
disease (37, 50). 20 
Steady state BCG cells grown at a slow dilution rate of 0.01 h –1  (td = 69 h) were 21 
compared with cells growing at a higher growth rate of 0.03 h-1 (td = 23 h). A 22 
doubling time of 23 hours was adopted in this study to represent the acute phase of 23 
infection. This growth rate has recently been demonstrated experimentally in the 24 
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lungs of mice during early infection (52). The slower dilution rate of 0.01h-1 is 1 
proposed to correspond to a persistent mycobacterial infection. The average growth 2 
characteristics of BCG at these growth rates, once the steady state has been reached, 3 
(Table 1), are in good agreement with Monod’s standard mathematical model for 4 
microbial population dynamics in the chemostat (for reviews of the model see (22, 28, 5 
39). There were 5.1 times as many cells per gram in cultures grown at the fast growth 6 
rate (td = 23 h) as in cultures grown at the slower growth rate (td = 69 h). This is 7 
consistent with the fast growing mycobacterial cells being much larger than slower 8 
growing cells (15). The yield constant (defined as the mass of bacteria formed divided 9 
by the mass of substrate consumed) decreased at the higher dilution rate, as is usually 10 
observed (22).  11 
The macromolecular composition of microbial cells has been shown to change with 12 
environmental conditions and specific growth rate (6, 15). Here the macromolecular 13 
composition of BCG cells was experimentally determined at two different growth 14 
rates in the carbon limited chemostats (Table 1). A large percentage (63-67%) of the 15 
dry cell weight of BCG was found to be carbohydrate and lipid, whereas a much 16 
smaller percentage of the biomass is made up of protein, RNA and DNA. 17 
Mycobacterial cell composition was therefore shown to be very different to that of 18 
E.coli. In E. coli 75-91% of the dry weight is protein and nucleic acids, with 19 
carbohydrates, lipids, soluble metabolites and salts comprising the remaining dry 20 
mass (6). However, in common with E. coli, it was found that the sum of the 21 
percentage dry weights of protein, RNA and DNA was independent of growth rate 22 
(8).  23 
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The proportion of protein measured by two independent methods was identical and 1 
showed that the protein content of a mycobacterial cells remains relatively constant at 2 
21-22% (wt/wt); it falls slightly as the growth rate increases. The validity of the 3 
protein data was further confirmed by the results of the elemental (CHN) analysis. 4 
This protein concentration is much lower than predicted by Cox (53.70%) (10-12) but 5 
is in the same magnitude as the concentration reported for Mycobacterium 6 
tuberculosis (67). These data also show that the pools of RNA and lipid increased 7 
with the specific growth rate, whereas the pool of carbohydrate decreased. The 8 
greatest change was observed in the RNA component reflecting the increasing 9 
concentration of ribosomes at higher growth rates (6). The sum of the proportions of 10 
protein, RNA, DNA, lipid and carbohydrate correspond to 90-93% of the total dry 11 
weight; the remaining 7-10% can be accounted for by soluble metabolites and salts 12 
(6).  13 
A stoichiometric composition model for M. bovis BCG. To obtain a detailed 14 
inventory of the mycobacterial cell a macromolecular composition model was 15 
constructed and the elemental composition of the component macromolecules 16 
calculated. This is a strategy which has been employed by others and is an important 17 
step in the development of a metabolic network such as those used in metabolic flux 18 
analysis (14). The average amino acid composition of the protein component was 19 
obtained from the Horizontal Gene Transfer Database website (URL: 20 
http://www.fut.es/~debb/HGT/) (20). RNA and DNA compositions were calculated 21 
assuming a GC content of 65.6% and the constituents of the average carbohydrate 22 
were calculated from Winder et al (9, 65). The elemental composition of lipids was 23 
obtained experimentally by determining the CHN values for extracted lipids. Using 24 
the resulting composition model (Table 2) the elemental biomass compositions were 25 
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calculated from the macromolecular biomass data and compared to experimentally 1 
determined CHN data. At growth rates of 0.01 h-1 and 0.03 h-1, a composition of 2 
C1.000H2.046N0.109O 0.726P 0.005S 0.002X (Mr = 27.43 g mol -1) and C1.000H2.038N0.107O 3 
0.810P 0.007S 0.001X  (Mr = 28.93 g mol -1), respectively were calculated, X denoting less 4 
important elements. These values are in good agreement with the experimentally 5 
determined values of C1.000H1.97N0.114  (Mr = 26.15 g mol -1) and C1.000H1.915N0.1124  6 
(Mr = 29.43 g mol -1) thus validating the results. 7 
The mycobacterial cell. To estimate the size and intracellular concentrations of the 8 
mycobacterial cell and also to facilitate comparison with other published data it was 9 
necessary to convert the macromolecular and elemental data from per gram of dry 10 
weight to per cell. However, as viable counts are a notoriously inaccurate measure of 11 
cell number in mycobacteria due to clumping, cell numbers were estimated using the 12 
quantity of DNA in the biomass (Table 1) (8, 11). All values needed for the 13 
calculations were experimentally determined except for the number of genomes per 14 
cell, which was calculated using the equation G = (tD/C ln2) {[2(C + D/ tD]/ tD –2 (D/ 15 
tD)}(8, 10, 23). This equation was derived to calculate the number of genomes in the 16 
cell during balanced growth in terms of the doubling time (td), the time taken to 17 
replicate the genome (C) and the period of time between the end of DNA synthesis 18 
and cell separation (D)(8). A C period of 10.33 hours has been measured for M. 19 
tuberculosis and although no data is available for the D period, it has been estimated 20 
to be approximately 6 hours (10, 11, 23). The number of genomes per cell was 21 
calculated as 1.12 at a dilution rate of 0.01h-1 and 1.40 at a dilution rate of 0.03h-1.  22 
The amount of RNA reflects number of ribosomes in the cell and therefore in 23 
accordance with expectations the RNA content per cell increases from 2.11 fg per cell 24 
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at µ = 0.01 h-1 to 9.96 fg per cell at µ=0.03 h-1 to accommodate the growth rate 1 
demand (Table 3). There are no data on the relative concentration of mRNA, tRNA 2 
and rRNA in mycobacteria but in E. coli the relative content is 2%, 15% and 83% 3 
respectively (6). Although at very low growth rates the tRNA content increases at the 4 
expense of rRNA, rRNA levels are considered to be relatively constant at most 5 
growth rates (53). Using these values and the molecular weight of RNA in a 6 
M. tuberculosis ribosome the number of ribosomes per cell could be estimated (9). In 7 
addition under steady state growth and assuming negligible or constant protein 8 
turnover ribosome efficiency can be shown to equal µ.P/R, where µ is specific growth 9 
rate and P and R are the amount of cellular protein and ribosome content (number) (6, 10 
10). According to such calculations, the slow growing cells contained 687 ribosomes 11 
with an efficiency of 0.00055 (fg protein synthesised per ribosome per hour), and the 12 
fast growing cells contained 3880 ribosomes with an efficiency of 0.00056. The 13 
ribosomal efficiency is 21 times lower than the maximum efficiency reported for E. 14 
coli and appears to be independent of growth rate, a characteristic which has been 15 
reported for other bacteria (46, 49, 55)   16 
Lipid and carbohydrate make up a large proportion of the BCG cell. At a specific 17 
growth rate of 0.03h-1 the cells contained 124.80 fg and 57.31 fg of each respectively.  18 
Values of 54 fg carbohydrate and 76 fg lipid were reported by Winder and Rooney 19 
(69) for M. bovis BCG growing in batch cultivation. As data here shows that the lipid 20 
content decreases with the growth rate, the differences in these observations are likely 21 
to be a reflection of the growth rate and culture conditions of the experiments. The 22 
correlation between growth rate and the lipid content of M. bovis BCG reflects a 23 
change in the pool of intracellular reserves, which may have particular significance 24 
for mycobacteria when growing in the host.  25 
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DISCUSSION 1 
A model experimental system for studying mycobacterial growth in carbon-limited 2 
chemostats was developed during this study, allowing for a complete description of 3 
the changes in the cells’ (macro)molecular composition at different physiological 4 
states. In this model two growth rates were investigated to simulate possible growth 5 
rates at different stages of TB infection. A fast growth rate of 0.03 h-1 (td=23hrs) is 6 
representative of cells during active disease whilst a slower growth rate of 0.01 h –1  7 
(td=69hrs) is proposed to correspond to a persistent mycobacterial infection (52). This 8 
model provided ideal conditions for analysing the physiology of mycobacteria at 9 
different growth rates and these results provide the first reliable descriptions of the 10 
effects of growth rate on the macromolecular and elemental composition of the 11 
mycobacterial cell. In addition the stoichiometric model of macromolecular cellular 12 
composition constructed in this study allows the precursor requirements for M. bovis 13 
BCG to be predicted and is therefore an important first step in the development of a 14 
metabolic flux network for the tubercle bacillus. 15 
In recognition of the importance of this topic a theoretical framework was recently 16 
developed to examine the growth of M. bovis BCG using macromolecular 17 
compositions from a limited amount of data reported in the 1970’s (11, 12, 64).  The 18 
general growth related trends in the proportions of protein, RNA and DNA for 19 
M. bovis BCG presented in this study follows a very similar pattern to the behaviour 20 
predicted by the mathematical model (11). There are however significant 21 
discrepancies between the previous observations with batch cultured M. bovis BCG 22 
and the results presented here (64). Most significantly the amounts of protein and 23 
RNA in continuously grown cultures are less than those previously predicted and as a 24 
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consequence the macromolecular composition equations derived by Cox (11) were 1 
found not to apply to chemostat grown M. bovis BCG cells. 2 
It is difficult to interpret the significance of this discrepancy. The data used in the 3 
previous study were obtained from cells cultured for 6 days prior to sampling and 4 
therefore as observed by Winder and Rooney the bacteria were not in exponential 5 
growth phase (64). This compromises the validity and accuracy of the data. In 6 
contrast, the bacterial cells at the steady state reached in the chemostat are 7 
physiologically homogenous, evenly distributed in a glycerol-limited environment and 8 
are all replicating at a controlled rate. Therefore the overall macromolecular 9 
composition determined for the whole population can be averaged over all the cells in 10 
the population.  11 
The RNA to protein ratio is a rough measure of the physiological state of cells. The 12 
significance of this ratio lies in its close relationship to the ribosome synthesis rate, 13 
which is a measure of the metabolic activity the cell devotes to ribosome synthesis. It 14 
has been demonstrated here that the RNA: protein ratio increases with growth rate, a 15 
property that has been reported for other bacteria and reflects changes in the rRNA 16 
concentrations of the cell. The notion that ribosomes function at a constant maximum 17 
efficiency and that an increase in growth rate can only be achieved by increasing 18 
ribosome concentration has become a central dogma in bacterial physiology.  The 19 
relative constancy of the ribosome efficiencies calculated for M. bovis BCG is in 20 
accordance with this theory. The earlier studies by Winder and Rooney (64) suggested 21 
that BCG maintain a constant level of ribosome synthesis and may not be capable of 22 
altering cellular ribosome levels by regulating synthesis. Cross species experiments 23 
have shown that the two promoters of the rrn operon of M. tuberculosis are both 24 
 19
subject to growth rate dependent control (GRDC) in the environment provided by 1 
M. smegmatis, although other investigators have demonstrated that the rate of rRNA 2 
transcription initiation did not vary between the logarithmic and stationary phase of 3 
growth, leading the authors to conclude that GRDC of rRNA does not occur in 4 
M. tuberculosis (38, 57). The current study indicates that this is not the case, as the 5 
amount of RNA alters significantly as a function of growth rate, suggesting that the 6 
BCG rrn promoters are subject to GRDC under carbon limiting conditions. 7 
Mycobacteria dedicate large amounts of energy towards making lipids for the 8 
construction of the cell wall and also for storage purposes. Lipid was the main 9 
component of the carbon limited cells and the fast growing cells contained twice as 10 
much lipid as the slow growing cells. Research has shown that the total lipid content 11 
both increases and decreases during the growth of mycobacterial cultures (7, 44). This 12 
is likely to be a consequence of changes in availability of carbon, which can be 13 
converted into lipid. The lipid composition values obtained for chemostat-grown cells 14 
from carbon limited cultures in this study are therefore likely to represent the 15 
minimum proportions of lipid required to maintain cellular metabolic and structural 16 
requirements at the imposed growth rate. The increased lipid composition observed at 17 
the fast growth rate may reflect a build up of energy reserves, which could be relevant 18 
to the survival of mycobacteria during persistence.  19 
Nutrient limitation is likely to be a feature of the microenvironment of M. tuberculosis 20 
in vivo as the growth substrates available are dependent on the host’s metabolic 21 
activities. Although investigations of intracellular survival of various auxotrophic 22 
mutants can give clues to nutrient availability inside the host, the precise composition 23 
of each niche can only be guessed (26, 47). Carbon was chosen as the rate limiting 24 
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nutrient in this study as evidence suggests that the phagosomal environment is 1 
carbohydrate-limited (50). The effect of starvation on mycobacterial cell physiology 2 
has previously been studied by simply resuspending cells in phosphate buffer (5). 3 
More recently the effects of nutrient depletion on the transcriptome of M. tuberculosis 4 
has been investigated using extended stationary phase culture in a bioreactor (21). 5 
This system allowed the pH, temperature and dissolved oxygen tension to be kept 6 
constant throughout the experiments. Although this model goes some way to address 7 
the problems associated with flask batch cultivations, the stationary phase of growth 8 
remains a very poorly defined condition. The mixture of cells in different states of 9 
growth and death leads to a fluctuating environment. Indeed by the end of 100-day 10 
culture in the extended stationary phase model 99% of the original culture had died, 11 
with the concomitant release of toxins and metabolites that would impact on the 12 
physiological state of the surviving organisms (21). In contrast, the effect of carbon-13 
limitation can be studied in isolation in the chemostat model provided by this study. 14 
The specific response of the cell to carbon limitation can therefore be elucidated.  15 
Another important issue to be addressed is the calcualtion of the distribution of 16 
metabolic fluxes under the different physiological conditions studied. MFA is a 17 
powerful methodology for the analysis of metabolic pathways. This technique has 18 
already proved to be an invaluable tool in metabolic engineering and has been used to 19 
successfully to identify novel pathways in bacteria, providing an enormous potential 20 
in functional genomics (18). MFA calculates intracellular fluxes using a combination 21 
of mathematical and experimental modeling. The minimum requirements for MFA 22 
are; (1) assembly of a metabolic flux network; (2) cultivation of the organism under 23 
steady state conditions; (3) specific measurements including the macromolecular 24 
composition of biomass and extracellular metabolites. This study describes an 25 
 21
appropriate system (i.e. chemostat cultures) for performing metabolic flux analysis 1 
and also provides data that could be used as input to a metabolic flux network. In 2 
addition the stoichiometric model of macromolecular cellular composition contributed 3 
to a metabolic flux matrix that is currently under development in our laboratory. MFA 4 
has never been attempted using M. tuberculosis, however given the importance that 5 
shifts of metabolism might have to the virulence of this pathogen this technique could 6 
have a significant impact on mycobacterial research.  7 
Models of persistence have focused on inducing a static state in which mycobacteria 8 
are not growing or dying, however the state of bacterial growth at sites of latent TB is 9 
unknown (5, 58). Slow growth rates and nutrient limitation may mimic the in vivo 10 
environment of persistent mycobacteria and therefore studies such as the one 11 
presented here will reveal important clues about the physiology of presistence. This 12 
model could also be particularly useful for testing the sterilising activities of new anti-13 
tubercular drugs targeted towards persistent mycobacteria.  14 
This study provides a macromolecular composition of glycerol limited BCG cells at 15 
specific and well defined growth rates. Extending these studies to include additional 16 
growth rates and other carbon sources would allow more detailed understanding of 17 
how organisms structure their cells in response to their environment. It has been 18 
proposed that M. tuberculosis primarily metabolises lipid in the host (51, 59). 19 
Investigating the physiological state of lipid limited mycobacterial cells will therefore 20 
be an important extension of this work and may help define the status of the M. 21 
tuberculosis cell in vivo. 22 
 23 
 24 
 22
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TABLE 1. Characteristics and composition of M. bovis BCG grown 
in continuous culture at two growth rates a 
 Units   
Dilution rate h-1 0.01 0.03 
Doubling time h-1 69.30 23.10 
Optical density (600nm)  1.91 0.83 
CFU 106 ml-1 163 4.64 
Bacterial concentration g dry wt l-1 2.2 0.32 
Yield constant g bacteria g 
glycerol-1 
0.30 0.36 
Protein content % 22.91 21.40 
RNA content % 1.28 3.58 
DNA content % 3.21 2.19 
Carbohydrate content % 29.20 21.91 
Lipid Content % 33.90 44.82 
a Values represent averaged data from two independent chemostat 
experiments. Cultures were assumed to be in the steady state when 
carbon dioxide and biomass production remained constant. All assays 
were performed a minimum of three times. 
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TABLE 2. Stoichiometric model of M. bovis BCG macromolecular 
compartments 
Amino acids and nucleotides are represented by their three letter 
codes 
Amino acidsa DNAb Carbohydratec 
% (wt/wt) % (wt/wt) % (wt/wt) 
Ala 9.41 dAMP 17.42 Trehalose 7.78 
Arg 10.87 dCMP 30.81 Polysaccharide 4.67 
Asp 2.43 dGMP 34.83 Glucose 13.97 
Asn 6.18 dTMP 16.95 Mannose 8.14 
Cys 0.97   Oligosacharide 0.12 
Glu 
3.63 
  
6-O-
methylglucose 
0.83 
Gln 5.53 RNAb Galactose 0.84 
Gly 5.47 % (wt/wt) Arabinose 19.86 
His 2.86 AMP 18.53 Ribose 1.55 
Ile 4.41 CMP 31.12 Galactose 3.91 
Leu 10.18 GMP 34.98 Glucosamine 32.73 
Lys 2.46 UMP 16.37 Muramic acid 4.49 
Met 2.27   Glycerol 1.11 
Phe 3.83     
Pro 5.43   Lipidd 
Ser 4.71   % (wt/wt) 
Thr 5.62   Carbon 52.75 
 25
Trp 2.45   Hydrogen 1.64 
Tyr 3.04   Nitrogen 9.54 
Val 8.25   Oxygen 36.07 
a The amino acid composition of an average M. tuberculosis protein 
was calculated from data on the website 
http://www.fut.es/~debb/HGT/ (20). 
b RNA and DNA compositions were calculated with a GC content of 
65.6% (9). 
c The constituents of an average carbohydrate were calculated from 
data of Winder and Rooney (69).  
d The elemental lipid composition was determined experimentally 
using a CHN analyzer (this paper). 
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 2 
 3 
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TABLE 3. Macromolecular properties of carbon 
limited M. bovis BCG cells cultured at two specific 
growth rates in a chemostat 
 Units   
Dilution rate  h-1 0.01 0.03 
Doubling time (tD) h-1 69.30 23.10 
Genomes per cella  1.12 1.40 
DNA per cellb fg 5.35 6.73 
RNA per cell fg 2.24 9.96 
Ribosomes per cellc  686.58 3879.61 
Protein per cell fg 37.74 72.07 
Carbohydrate per 
cell 
fg 49.06 60.93 
Lipid per cell fg 57.31 124.79 
RNA:Protein  0.059 0.138 
RNA:DNA  0.419 1.480 
 27
aThe number of genomes per cell was calculated 
using the formula G = (tD/C ln2) {[2(C + D/ tD]/ tD 
–2 (D/ tD)} using the values C=10.33 h and D=6 h 
(8, 10, 23). 
bThe weight of the genome was calculated as 4.79 
fg (9). 
cThe numbers of ribosomes were calculated on the 
basis that rRNA comprises 83% of total RNA and 
that each M. bovis BCG ribosome consists of 4790 
nucleotides (9, 12).  
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